ComplianceOnline

Regulation of Asset-backed Securities: SEC Approves New Rules

  • Date: January 26, 2011
  • Source: Admin
Webinar All Access Pass Subscription Abstract:

The Securities & Exchange Commission (SEC) voted on Jan 20, 2011 to adopt two sets of new rules. The said rules are meant to help revive the important asset-backed securities (ABS) market by encouraging better disclosure for investors. The first set of rules requires issuers of asset-backed securities to disclose the history of the requests they received and the repurchases they made related to their outstanding asset-backed securities. The second set of rules requires issuers of asset-backed securities to conduct a review of the assets underlying those securities.  

Disclosure for Asset-Backed Securities Related to Representations, Warranties and Repurchase


Section 943 of the Dodd-Frank Act requires the SEC to prescribe regulations on the use of representa-tions and warranties in the market for asset-backed securities. The final rules approved on Jan 20, 2011, and proposed in October 2010, implement Section 943.

Requirements of the Final Rules (adopted new rules)

The final rules require:

  • Disclosure of Repurchase History on New Form ABS-15G
  • Disclosure of Repurchase History in Prospectuses and Ongoing Reports
  • Disclosure in Any Report Accompanying a Credit Rating by an NRSRO


Issuer Review of Assets Underlying Asset-Backed Securities

Section 945 of the Dodd-Frank Act requires the Commission to adopt rules regarding the review of as-sets, such as loans, underlying asset-backed securities. The final rules approved today, which were proposed in October 2010, implement Section 945.

Requirements of the Final Rules (adopted new rules)

The final rules require:

  • Issuers of ABS in Registered Offerings to Perform a Review of the Assets
  • Issuers of ABS to Disclose Information about their Reviews


Any registered offering of ABS commencing with an initial offer after Dec. 31, 2011, must comply with the new rules if they're adopted by the Commission.

  Source:

http://www.sec.gov/news/press/2011/2011-18.htm

 

Bookmark and Share

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
Live February 11, 2026
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading